We use cookies to help provide you with the best possible online experience. Please read our Privacy Policy for information about which cookies we use and what information we collect on our site. By continuing to use this site, you agree that we may store and access cookies on your device.
The Appointments Committee of the Union Cabinet appointed Kamlesh Kumar Pant, a 1993-batch IAS officer of Himachal Pradesh cadre as the new chairman of National Pharmaceutical Pricing Authority (NPPA) as a part of senior-level bureaucratic reshuffle.
Genesis Biotechnology Group (GBG) and its Contract Research Organization (CRO) arm Genesis Drug Discovery & Development (GD3) have acquired the Berkeley-based CRO Integrated Analytical Solutions (IAS).